| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/19/2005 | US20050106125 Nucleic acid gene expression; insertion of adeno-associated virus; inverted terminal repeat sequences ; anticancer agents |
| 05/19/2005 | US20050106124 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 05/19/2005 | US20050106099 Fusion proteins |
| 05/19/2005 | DE19905501B4 Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels A method of producing a recombinant adeno-associated virus, as well as suitable means to this end use for the preparation of a medicament |
| 05/19/2005 | DE10148828B4 Modulation der Expression STAT-1-abhängiger Gene Modulating the expression of STAT-1-dependent genes |
| 05/19/2005 | CA2544807A1 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 05/19/2005 | CA2543719A1 Methods and compositions for modulating apoptosis |
| 05/19/2005 | CA2541643A1 Rna interference mediated inhibition of hairless (hr) gene expression using short interfering nucleic acid (sina) |
| 05/18/2005 | EP1531181A2 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes |
| 05/18/2005 | EP1531161A2 Human epidermal proteins HEPI-1 to HEPI-6 |
| 05/18/2005 | EP1530970A1 Composition and method for inducing immune tolerance towards cell, tissue and/or organ transplants |
| 05/18/2005 | EP1530725A1 Materials and methods for inductions of immune tolerance |
| 05/18/2005 | EP1530724A2 Diagnosis and prevention of cancer cell invasion |
| 05/18/2005 | EP1530638A2 T-cell epitopes in staphylococcal enterotoxin b |
| 05/18/2005 | EP1530632A2 Growth factor which acts through erb b-4 rtk |
| 05/18/2005 | EP1530585A2 Inducible alphaviral/orip based gene expression system |
| 05/18/2005 | EP1530584A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 05/18/2005 | EP1530582A2 Diagnosis of kidney damage and protection against same |
| 05/18/2005 | EP1530482A1 Use of urease for inhibiting cancer cell growth |
| 05/18/2005 | EP1341909B1 A method for in vitro molecular evolution of protein function |
| 05/18/2005 | EP1034185B1 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 05/18/2005 | EP0844888B1 Adenovirus vectors comprising a prostate specific antigen (psa) response element |
| 05/18/2005 | EP0839055B1 Modified methioninase, its use, recombinant host cells producing high levels of methioninase and method for purifying methioninase |
| 05/18/2005 | EP0662137B1 Gene transcription and ionizing radiation: methods and compositions |
| 05/18/2005 | CN1617928A Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 05/18/2005 | CN1617890A Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 05/18/2005 | CN1617888A Bispecific antibody DNA constructs for intramuscular administration |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617745A Stabilized formulations of adenovirus |
| 05/18/2005 | CN1617740A Immunisation against chlamydia trachomatis |
| 05/18/2005 | CN1617732A Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 05/18/2005 | CN1617710A Liposome composition for delivery of nucleic acid |
| 05/18/2005 | CN1616670A 感染性克隆 Infectious clone |
| 05/18/2005 | CN1616665A Targeted liposome gene delivery |
| 05/18/2005 | CN1616663A O type foot and mouth disease virus DNA vaccine and its preparing method |
| 05/18/2005 | CN1616661A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 05/18/2005 | CN1616476A Small interference ribonucleic acid molecule for epidermal growth facor gene and its use |
| 05/18/2005 | CN1616110A SARS yeast crossbreeding vaccine and its preparing method |
| 05/18/2005 | CN1616109A Method for MG 7-Ag analogue epitope to construct stomack cancer specific poly epitope gene vaccine |
| 05/18/2005 | CN1616108A Novel mucous membrane vaccine for newcastle disease and its construction method |
| 05/18/2005 | CN1616107A Gene engineering recombined vaccine of carcinoma of cervix uterus |
| 05/18/2005 | CN1616106A Method for preparing biological preparation for improving pig growth |
| 05/18/2005 | CN1202257C Recombination carrier and treating composition used in insulin dependent diabetes gene curing |
| 05/17/2005 | US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 05/17/2005 | US6894154 Medical equipment comprising nucleic acid codes for wild-type human kinase interacting stathmin (hKIS) phosphoproteins, used for drug delivery; antiproliferative agents |
| 05/17/2005 | US6894031 Polynucleotides; in situ injection |
| 05/17/2005 | US6894021 Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation |
| 05/17/2005 | US6893870 Pancreas-derived plasminogen activator inhibitor |
| 05/17/2005 | US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 05/17/2005 | US6893867 Molecular switch for regulating mammalian gene expression |
| 05/17/2005 | US6893865 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles |
| 05/17/2005 | US6893858 Human kcnq5 potassium channel, methods and compositions thereof |
| 05/17/2005 | US6893844 DNA encoding a new human hepatoma derived growth factor and producing method thereof |
| 05/17/2005 | US6893841 Nucleotide sequences coding polypeptide for use in tool in treatment of defects in protein transport |
| 05/17/2005 | US6893664 Particle delivery techniques |
| 05/17/2005 | US6893643 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen |
| 05/17/2005 | US6893634 Without inflammatory or other immune response side effects; injection or implantation in tissue containing cancer growth; porous cellulose sulphate and polydimethyldiallylammonium membrane; breast and/or pancreatic tumors |
| 05/17/2005 | CA2304987C Inhibition of an fgf-binding protein using ribozymes |
| 05/12/2005 | WO2005042782A1 Methods for reducing seizure-induced neuronal damage |
| 05/12/2005 | WO2005042740A1 Method of enhancing hematopoiesis-supporting ability of immortalized human bone marrow stroma cell by transferring indian hedgehog gene |
| 05/12/2005 | WO2005042727A2 Methods of organ regeneration |
| 05/12/2005 | WO2005042714A2 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 05/12/2005 | WO2005042702A2 Compositions of stabilized dna for coating microprojections |
| 05/12/2005 | WO2005042576A1 Clq RELATED PROTEIN |
| 05/12/2005 | WO2005042558A1 Iap nucleobase oligomers and oligomeric complexes and uses thereof |
| 05/12/2005 | WO2005042552A2 Modulation of sglt2 expression |
| 05/12/2005 | WO2005042018A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 05/12/2005 | WO2005042002A2 Treatment of rhematoid arthritis with flip antagonists |
| 05/12/2005 | WO2005041874A2 Method and antisense composition for selective inhibition of hiv infection in hematopoietic cells |
| 05/12/2005 | WO2004108938A3 Peptide ligands of dendritic cells for nucleic acid vector targeting |
| 05/12/2005 | WO2004094642A3 Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
| 05/12/2005 | WO2004044137A3 Modified oligomeric compounds and compositions for use in gene modulation |
| 05/12/2005 | WO2004029281A3 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals |
| 05/12/2005 | WO2004018502A8 Compounds binding to p-selectin |
| 05/12/2005 | WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/12/2005 | WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 05/12/2005 | US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents |
| 05/12/2005 | US20050101762 Cyclic peptide for use as tool in transmembrane transport; drug delivery |
| 05/12/2005 | US20050101559 Contacting tissues agents that increase vascular permeability to an exogenous nucleic acid followed by administering exogenous nucleic acid under a low calcium ion concentration; transfer efficiency is increased |
| 05/12/2005 | US20050101557 Immunostimulatory nucleic acid molecules |
| 05/12/2005 | US20050101556 Genetic engineering; Alzheimer's disease; anticancer agents |
| 05/12/2005 | US20050101555 Antisense modulation of caspase 7 expression |
| 05/12/2005 | US20050101554 Methods for treating and preventing infectious disease |
| 05/12/2005 | US20050101552 Neurodegenerative disease; demyelination diseases; brain disorders; screening stem cells in brain; animal models; Alzheimer's, Parkinson's, Huntington's disease |
| 05/12/2005 | US20050101536 Modulation of angiogenesis |
| 05/12/2005 | US20050101530 Cellular virus receptors and methods of use |
| 05/12/2005 | US20050101525 Method of complexing a nucleic acid with a lipid-conjugated polyamide |
| 05/12/2005 | US20050101018 Viral vector encoding pigment epithelium-derived factor |
| 05/12/2005 | US20050101013 Antisense nucleotide sequences for modulating the expression of signal transducer and activator of transcription (STAT) proteins; cancer and tumor treatment; gene expression inhibition |
| 05/12/2005 | US20050100963 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 05/12/2005 | US20050100940 Novel FDRG protein and nucleic acid molecules and uses therefor |
| 05/12/2005 | US20050100924 C/EBPalpha gene targeting constructs and uses thereof |
| 05/12/2005 | US20050100918 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100917 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100913 RNA interference pathway genes as tools for targeted genetic interference |
| 05/12/2005 | US20050100907 Method and medicament for inhibiting the expression of a given gene |
| 05/12/2005 | US20050100890 Viron for use as gene transfer construct; gene therapy and tissue targeted therapy; drug delivery |
| 05/12/2005 | US20050100885 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| 05/12/2005 | US20050100539 Enzymes useful for treating and methods for treating MPS-VI and cells lines for producing such enzymes recombinantly |
| 05/12/2005 | US20050100527 Liposomes for transfection of nucleic acids |